Cell-free extracts of Streptomyces bikiniensis contain an adenosine 5'-triphosphate-dependent kinase which inactivates streptomycin (Sm) and dihydrostreptomycin by phosphorylation. The products have been identified as streptomycin 6-phosphate and dihydrostreptomycin 6-phosphate. Activity was not present in logarithmic-phase cells, which were susceptible to 25 ug of Sm per ml. In stationary-phase cells, activity appeared 12 h before detectable Sm in the medium. between the uptake of [3H]dihydrostreptomycin and resistance. The Sm-inactivating enzyme was identified as streptomycin-6-kinase. These results suggest that phosphorylation by streptomycin-6-kinase is a major factor in resistance in S. bikiniensis.
Streptomycin (Sm) is a potent inhibitor of procaryotic protein synthesis (17) . Some microorganisms, however, are resistant to Sm because of either a decreased permeability to the drug (28) , altered binding sites for the drug (1), or enzymes which modify the drug (1) . Sm-producing procaryotes must also have mechanisms for escaping the effects of Sm, at least during the antibiotic production phase of their growth. It has been suggested (1, 10, 16 ) that the mechanisms of resistance developed by antibiotic-producing microorganisms to their own antibiotics are probably the same as those evolved by resistant microorganisms that do not produce antibiotics. Sm-modifying enzymes have been reported in Sm producers (16, 21, 22) . These enzymes may be involved in the detoxification of Sm and the resistance mechanism in Sm-producing strains (1, 4, 16 ; L. C. Vining, Annu. Meet. Am. Chem. Soc., Abstr. no. 42, 1978) ; however, there is only circumstantial evidence to support this suggestion. In addition, studies on an Smproducing Streptomyces griseus strain suggest that decreased permeability may be involved in resistance in that microorganism (4) .
Streptomyces bikiniensis ATCC 11062 produces and is resistant to Sm. Treatment of spores of S. bikiniensis with acriflavine or ethidium bromide results in loss of both the ability to produce Sm and resistance to Sm in 2 to 16% of the colonies obtained from surviving cells (19) . We examined the mechanism of Sm resistance in S. bikiniensis by using as controls dye-treated, Sm-susceptible isolates derived from the parent strain. Dye-treated isolates and parent strain cells were examined for the presence of Sminactivating enzymes, differences in Sm permeation, and differences in the susceptibility of the protein synthesis system to Sm.
MATERIALS AND METHODS
Bacterial strains and media. Stock cultures of S. bikiniensis ATCC 11062 and all isolates derived from it (dye-treated isolates) were maintained in sterile soil. Cultures were transferred to yeast malt extract (YMX) agar (Difco Laboratories) for use in the experiments. Unless otherwise stated, cells were grown in 2% peptone -0.2% yeast extract (PYX) medium. Spores from YMX agar slants were suspended in 5 ml of 0.05% Triton X-100. A 1-ml amount of the suspension was transferred to 100 ml of PYX medium. Cells were incubated at 260C in a reciprocal shaker. Escherichia coli C600 was maintained on nutrient agar (Difco) and was grown in nutrient broth (Difco).
Growth curve determination Spores from an agar slant were suspended in 10 ml of 0.05% Triton X-100. A 1-ml amount of the suspension was transferred to 30 ml of PYX medium in a 125-ml flask. Cells were harvested by centrifugation at various times after inoculation, and cell weight was determined after drying to (18) .
Sm-inactivating enzymes. Cell-free extracts were prepared by the technique of Walker and Walker (22) in TMS buffer [10 mM tris(hydroxymethyl)aminomethane hydrochloride, 10 mM magnesium chloride, 25 mM ammonium chloride, 0.6 mM ,-mercaptoethanol, pH 7.8]. Protein determinations were made by using the colorimetric assay of Lowry et al. (15) . Assay mixtures containing equal volumes of cell-free extracts of dye-treated isolates or parent strain cells, 1 mM streptomycin sulfate, 40 mM adenosine 5'-triphosphate, disodium salt (ATP) (in water, pH 7.6), and 100 mM magnesium acetate were incubated for 1 h at 30°C. Portions of the reaction mixtures were assayed for biological activity as previously described (19) . Streptomycin kinase (Sm kinase) activity was assayed by the phosphocellulose-paper binding assay of Davies et al. (8) . Reaction volumes of 155 (22), and ion-exchange chromatography (16) . Radioactivity was detected on the paper chromatograms and electrophoretograms by autoradiography, using Kodak No Screen X-ray film (Eastman Kodak Co.), and in the ion-exchange column effluents by liquid scintillation counting in Bray scintillation fluid (2) .
RESULTS
Sm resistance. Sm-producing organisms have been reported to be susceptible to their own antibiotic during the logarthmic phase of their growth cycle. They develop resistance to Sm during the stationary phase of growth when antibiotic production begins (24) . Figure 1 shows the relationship between growth, Sm resistance, and antibiotic production in the parent strain of S. bikiniensis. Cells became resistant to Sm at the beginning of the stationary phase of growth, (Fig. 4) . The partially purified enzyme inactivated and phosphorylated Sm. The phosphorylated product formed by the purified enzyme had the same Rf on paper chromatograms and the same elution pattem on Bio-Rex 70 (NH4+) columns as SmP formed by the crude cell extracts.
Sm kinase activity could not be detected in cell-free extracts of logarithmic-phase, parent strain cells. Cells were susceptible to 50 Lg of Sm per ml at this stage in their growth cycle (Fig.  1) . Activity appeared at the beginning of the stationary phase of growth (24 h DHSmP formed in the reaction mixture. When analyzed by high-voltage electrophoresis, SmP and DHSmP had mobilities of -0.08 and -0.24 cm from the origin, respectively. These results are consistant with the phosphate being located on position 6 of the streptidine ring of Sm (20) . In addition, partially purified Sm kinase phosphorylated streptidine sulfate, although the extent of streptidine phosphorylation per milligram of protein was 20% that of Sm. DISCUSSION Development of antibiotic resistance at or shortly before antibiotic production begins has been reported in many antibiotic-producing organisms (11, 26) , including Sm producers (3, 24) .
The mechanisms by which resistance in antibiotic-producing microorganisms increases during their production phase have been reviewed recently (10). S. bikiniensis, an Sm producer, appears to follow this same pattern of resistance development. Logarithmic-phase cells are susceptible to Sm, whereas stationary-phase celLs are reistant to high levels of Sm (Fig. 1) . Treatment of S. bikiniensis with dyes results in loss of Sm resistance, as well as Sm production, with high frequency (19) , and the dye-treated isolates appeared to differ from parent strain cells only in their Sm susceptibility and lack of Sm production. Comparisons of parent strain celLs and dye-treated isolates at each stage of development therefore offered a means of distinguishing between factors that were involved only in the development of the culture (13) Alternatively, stationary-phase S. bikiniensis may escape the lethal effects of Sm by developing an Sm-insensitive protein synthesis system. In non-antibiotic-producing procaryotes this occurs through alteration of the 30S ribosomal subunit (7, 9) . Ribosomes from these organisms no longer bind Sm or DHSm (5, 12, 25) . Ribosomes from cells of S. bikiniensis which were resistant to Sm bound approximately the same amount of antibiotic as did ribosomes from cells which were susceptible to Sm (Table 2 ). It seems unlikely, then, that Sm resistance in stationaryphase S. bikiniensis was due to alteration in the binding of Sm to ribosomes. Similarly, the Sm tolerence of an Sm-producing S. griseus strain cannot be attributed to the presence of Smresistant ribosomes (3).
An Sm-inactivating enzyme was detected in cell-free extracts from parent strain S. bikiniensis cells which were resistant to high levels of Sm (Fig. 1) . Cell-free extracts from these cells also catalyzed the transfer of a phosphate group from ATP to the Sm molecule; 1 pmol of Sm was inactivated for each picomole of phosphate lost from the molecule (Fig. 3A) , suggesting that the inactivating enzyme was a kinase which phosphorylated Sm. In addition, biological activity could be restored by treating SmP with bacterial alkaline phosphatase (Fig. 3B) , and partially purified Sm kinase from these cells phosphorylated and biologically inactivated Sm.
Several Sm-phosphorylating enzymes have been reported (16, 22) , but their roles in Sm metabolism have not been clearly defined. Miller and Walker (16) have suggested that ATP:streptomycin-6-phosphotransferase (Sm-6-kinase), a stationary-phase enzyme found in S. bikiniensis, may serve to keep Sm in an inactive phosphorylated form before its secretion from the cell. Two additional phosphorylating enzymes have been reported in streptomycete species. S. griseus ATCC 10971 contains a kinase that phosphorylates the 3 position of the N-methyl-L-glucosamine ring. This enzyme phosphorylates the same position of the Sm molecule as Sm-inactivating enzymes from plasmid-containing enterobacteria (8) . A second phosphorylating enzyme has been reported in S. bikiniensis (ATP:dihydrostreptomycin -6 -P -3a'-phosphotransferase) which phosphorylates the 3a' position of the dihydrostreptose ring of DHSm. The products formed by all three of these enzymes can be identified by several means (20) . Results of paper chromatography, ion-exchange chromatography, and high-voltage electrophoresis of SmP and DHSmP formed by cell-free extracts and partially purified kinase are all consistent with the phosphate being located on the 6 position of the streptidine ring. The product of the kinase reaction and the ability of the enzyme to phosphorylate streptidine indicated that the enzyme involved in the inactivation of Sm is the Sm-6-kinase reported by Miller and Walker (16) .
Clinical isolates of Sm-resistant bacteria containing Sm-phosphorylating enzymes modify Sm by addition of a phosphate group at the 3 position of the N-methyl-L-glucosamine ring of Sm. The only known exception to this is a strain of Pseudomonas aeuriginosa which also phosphorylates the 6 position of the streptidine ring of Sm (14) . The possibility that antibiotic-producing organisms may be the source of genes for resistance-associated enzymes in these organisms has been suggested (1) . There is evidence to support this suggestion in kanamycin, gentamicin (1), and neomycin resistance (6) . Sm resistance seems an exception to this observation because the Sm-inactivating enzyme in S. bikiniensis differs from inactivating enzymes in plasmid-containing clinical isolates.
Sm-6-kinase activity paralleled the level of resistance in the parent strain (Fig. 5) . No enzyme activity was detected in dye-treated isolates at any stage in development and the iso-VOL. 16, 1979 on June 26, 2017 by guest http://aac.asm.org/ Downloaded from 182 PIWOWARSKI AND SHAW lates were susceptible to Sm throughout their growth. This indicates that Sm-6-kinase activity was closely related to the level of Sm resistance in S. bikiniensis. Our studies on the mechanism of Sm resistance in S. bikiniensis suggest that Sm-6-kinase plays a major role in the resistance mechanism. To our knowledge this is the first evidence that an Sm-phosphorylating enzyme confers resistance in a producing organism. In addition, the absence of Sm-6-kinase in the dyetreated isolates (19) suggests that resistance in S. bikiniensis may result from phosphorylation of Sm at the 6 position of the streptidine ring by a plasmid-encoded kinase.
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